Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,750.00p
   
  • Change Today:
    -50.00p
  • 52 Week High: 2,525.00
  • 52 Week Low: 1,366.67
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 8,839
  • Market Cap: £91.44m

Latest Deals

Traded Action Notifier PriceAmountValue
24-Jun-26 Buy Bruce Hiscock 1,799.00p 534 £9,606.66
27-Apr-26 Buy Bruce Hiscock 1,679.00p 66 £1,108.14
10-Apr-26 Buy Ian James Nicholson 1,848.00p 1,000 £18,480.00
08-Apr-26 Buy Peter John Harrison 1,849.00p 1,065 £19,691.85
08-Apr-26 Buy Peter John Harrison 1,849.00p 1,065 £19,691.85

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
08-Apr-26 Buy Peter John Harrison 1,849.00p 1,065 £19,691.85
08-Apr-26 Buy Peter John Harrison 1,849.00p 1,065 £19,691.85
04-Nov-25 Buy Peter John Harrison 2,220.00p 875 £19,425.00
04-Nov-25 Buy Peter John Harrison 2,220.00p 875 £19,425.00
10-Apr-26 Buy Ian James Nicholson 1,848.00p 1,000 £18,480.00

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 306,172 £5,358,010
Ian James Nicholson 14,500 £253,750
Bruce Hiscock 2,200 £38,500

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £91,343,980
Castlefield Fund Partners Limited 985,000 £17,237,500
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £15,487,500
Gresham House Asset Management Limited 627,782 £10,986,185
Miton Group plc 508,135 £8,892,362
The Diverse Income Trust plc 302,300 £5,290,250
Schroders plc 284,795 £4,983,912
Raymond James Wealth Management Limited 265,453 £4,645,428
Wasatch Advisors, Inc. 265,000 £4,637,500
Premier Miton Group plc 262,812 £4,599,210
Canaccord Genuity Group Inc 259,940 £4,548,950
SANFORD DELAND ASSET MANAGEMENT LTD 254,000 £4,445,000
Adrian Williams 253,372 £4,434,010

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 1,750.00p
Change Today -50.00p
% Change -2.78 %
52 Week High 2,525.00
52 Week Low 1,366.67
Volume 8,839
Shares Issued 5.22m
Market Cap £91.44m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  Interim 2nd Interim
Ex-Div 09-Apr-26 06-Nov-25
Paid 24-Apr-26 21-Nov-25
Amount 70.00p 80.00p

Trades for 21-Aug-2026

Time Volume / Share Price
16:44 1,000 @ 1,764.00p
16:24 152 @ 1,706.00p
16:19 99 @ 1,726.20p
15:59 200 @ 1,758.00p
15:57 45 @ 1,800.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page